New Key Statistics Module, Z-Score and F-Score
SZSE:300529 Key Ratios
Market Cap ¥ M | 21,674.78 |
Enterprise Value ¥ M | 20,485.05 |
P/E(ttm) | 41.48 |
PE Ratio without NRI | 40.36 |
Forward PE Ratio | -- |
Price/Book | 6.71 |
Price/Sales | 10.38 |
Price/Free Cash Flow | 24.78 |
Price/Owner Earnings | 110.75 |
Payout Ratio % | 1.01 |
Revenue (TTM) ¥ M | 2,094.00 |
EPS (TTM) ¥ | 0.65 |
Beneish M-Score | -3.59 |
10-y EBITDA Growth Rate % | 23.10 |
5-y EBITDA Growth Rate % | 10.30 |
y-y EBITDA Growth Rate % | -23.60 |
EV-to-EBIT | 29.79 |
EV-to-EBITDA | 29.79 |
PEG | 3.92 |
Shares Outstanding M | 807.56 |
Net Margin (%) | 25.06 |
Operating Margin % | 30.78 |
Pre-tax Margin (%) | 30.05 |
Quick Ratio | 2.73 |
Current Ratio | 2.99 |
ROA % (ttm) | 9.21 |
ROE % (ttm) | 15.90 |
ROIC % (ttm) | 20.02 |
Dividend Yield % | 1.48 |
Altman Z-Score | 6.82 |
SZSE:300529 Number of Guru Trades
SZSE:300529 Volume of Guru Trades
Gurus Latest Trades with SZSE:300529
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300529 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jafron Biomedical Co Ltd Insider Transactions
No Available Data